Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

The National Status of Tuberculosis Using Nationwide Medical Records Survey of Patients with Tuberculosis in Korea

  • Park, Yoon-Sung (Division of HIV and TB Control, Korea Centers for Disease Control and Prevention) ;
  • Hong, Sung-Jin (Division of HIV and TB Control, Korea Centers for Disease Control and Prevention) ;
  • Boo, Yoo-Kyung (Department of Healthcare Management, Eulji University) ;
  • Hwang, Eun-Suk (Research Department, Health Insurance Review and Assessment Service) ;
  • Kim, Hyun Jung (Division of HIV and TB Control, Korea Centers for Disease Control and Prevention) ;
  • Cho, Seung-Hee (Division of HIV and TB Control, Korea Centers for Disease Control and Prevention) ;
  • Na, Kyung-In (Division of HIV and TB Control, Korea Centers for Disease Control and Prevention) ;
  • Cho, En-Hi (Division of HIV and TB Control, Korea Centers for Disease Control and Prevention) ;
  • Shin, Sang-Sook (Division of HIV and TB Control, Korea Centers for Disease Control and Prevention)
  • Received : 2012.03.22
  • Accepted : 2012.06.05
  • Published : 2012.07.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The epidemiology of tuberculosis (TB) has been assessed based on the data of the analysis of TB patients notified to the surveillance system in Korea. However, the national status of TB is not validated through this surveillance system. The objective is to determine the epidemiology of TB and to understand the accurate status of TB patients treated in private institutions. Methods: Medical records of 53,579 patients who had been diagnosed with TB in 2008 were analyzed. Results: Among 53,579 patients, the number of sputum smear positive cases was 15,639(29.2%) and the number of new cases was 39,191 (73.1%). The drug resistance rate of new cases was 5.3%, while the rate stood at 13.3% for TB patients with treatment history. The number of multi-drug resistant TB (MDR-TB) patients was 2,472 (4.6%), which consists of 2.9% of new cases and 9.3% of TB patients with prior treatment history. The number of extensively drug-resistant TB patients was 749 (1.4%), consisting of 1.1% of new cases and 2.2% of TB patients with prior treatment history. In terms of treatment outcomes, 66.4% of all TB patients, 70.5% of new cases, 64.4% of relapse cases, and 46.8% of MDR-TB cases were cured or completed. It was inferred that in 2008, the total number of TB patients reached 70,767, 145.6 per 100,000 people (95% confidence interval, 145.5~145.7). Conclusion: We conclude that the medical records review of the Health Insurance Review and Assessment Service (HIRA) data can be very effective in promoting the understanding of the current status of TB in private institutions.

Keywords

References

  1. Kim YS, Park KH, Yoo HS, Kwon JW, Shin E. Reporting of national notifiable infectious diseases (NNIDs) and related characteristics. Korean J Epidemiol 2007;29:200-10.
  2. Korea Centers for Disease Control and Prevention. Annual report on the notified tuberculosis patients in Korea 2010. Cheongwon: Korea Centers for Disease Control and Prevention; 2011.
  3. Korea Centers for Disease Control and Prevention. Guidelines for national tuberculosis control, 2011. Cheongwon: Korea Centers for Disease Control and Prevention; 2011.
  4. World Health Organization. Treatment of tuberculosis guidelines 4th ed. Geneva: World Health Organization; 2009.
  5. Ministry of Health and Welfare, Korean Institute of Tuberculosis, Korean National Tuberculosis Association. Report on the 7th tuberculosis prevalence survey in Korea. Seoul: Korean Institute of Tuberculosis; 1996.
  6. Bai GH, Park YK, Choi YW, Bai JI, Kim HJ, Chang CL, et al. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004. Int J Tuberc Lung Dis 2007;11:571-6.

Cited by

  1. Relationship Between Serum 25-Hydroxyvitamin D and Lung Function Among Korean Adults in Korea National Health and Nutrition Examination Survey (KNHANES), 2008–2010 vol.98, pp.4, 2013, https://doi.org/10.1210/jc.2012-3901
  2. Increased Tuberculosis Burden Due to Demographic Transition in Korea from 2001 to 2010 vol.74, pp.3, 2012, https://doi.org/10.4046/trd.2013.74.3.104
  3. Diagnostic Accuracy and Turnaround Time of the Xpert MTB/RIF Assay in Routine Clinical Practice vol.8, pp.10, 2012, https://doi.org/10.1371/journal.pone.0077456
  4. Simultaneous detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in respiratory specimens vol.93, pp.6, 2012, https://doi.org/10.1016/j.tube.2013.07.007
  5. Risk Factors for Death during Pulmonary Tuberculosis Treatment in Korea: A Multicenter Retrospective Cohort Study vol.29, pp.9, 2012, https://doi.org/10.3346/jkms.2014.29.9.1226
  6. Diagnosis and treatment of multidrug-resistant tuberculosis vol.57, pp.1, 2014, https://doi.org/10.5124/jkma.2014.57.1.27
  7. Molecular Detection of Fluoroquinolone Resistance in Multidrug-ResistantMycobacterium tuberculosisIsolates vol.17, pp.3, 2014, https://doi.org/10.5145/acm.2014.17.3.80
  8. Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center vol.30, pp.3, 2012, https://doi.org/10.3904/kjim.2015.30.3.325
  9. Treatment of Drug Susceptible Pulmonary Tuberculosis vol.78, pp.3, 2012, https://doi.org/10.4046/trd.2015.78.3.161
  10. Medical Management of Drug-Resistant Tuberculosis vol.78, pp.3, 2012, https://doi.org/10.4046/trd.2015.78.3.168
  11. A Nationwide Multicenter Survey for Mycobacterial Testing in Korea vol.18, pp.3, 2012, https://doi.org/10.5145/acm.2015.18.3.69
  12. Diagnostic usefulness of the GenoType MTBDRplusassay for detecting drug-resistant tuberculosis using AFB smear-negative specimens with positive TB-PCR result vol.48, pp.5, 2016, https://doi.org/10.3109/23744235.2015.1122831
  13. Issues Related to the Updated 2014 Korean Guidelines for Tuberculosis vol.79, pp.1, 2012, https://doi.org/10.4046/trd.2016.79.1.1
  14. Paradoxical response as a cervical lymph node enlargement after termination of anti-tuberculosis treatment in a patient with pulmonary tuberculosis vol.31, pp.1, 2012, https://doi.org/10.7180/kmj.2016.31.1.71
  15. Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice vol.48, pp.6, 2012, https://doi.org/10.1183/13993003.00956-2016
  16. Effects of Corticosteroids on Critically Ill Pulmonary Tuberculosis Patients With Acute Respiratory Failure: A Propensity Analysis of Mortality vol.63, pp.11, 2016, https://doi.org/10.1093/cid/ciw616
  17. Performance of the GenoType MTBDR sl assay for the detection second-line anti-tuberculosis drug resistance vol.23, pp.12, 2012, https://doi.org/10.1016/j.jiac.2017.08.010
  18. Symptoms of Bacillus Calmette-Guerin Cystitis in Bladder Cancer Patients according to Tuberculosis Sequelae by Chest Radiography vol.12, pp.1, 2012, https://doi.org/10.14777/uti.2017.12.1.42
  19. The Rate of Drug-Resistant Tuberculosis in Korean Children and Adolescents Since 2007 vol.32, pp.6, 2012, https://doi.org/10.3346/jkms.2017.32.6.954
  20. WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update: Applicability in South Korea vol.80, pp.4, 2012, https://doi.org/10.4046/trd.2017.0049
  21. Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection vol.7, pp.None, 2012, https://doi.org/10.1038/s41598-017-06899-1
  22. Dual-time point 18F-FDG PET/CT for the staging of oesophageal cancer: the best diagnostic performance by retention index for N-staging in non-calcified lymph nodes vol.45, pp.8, 2012, https://doi.org/10.1007/s00259-018-3981-8
  23. CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression vol.6, pp.None, 2012, https://doi.org/10.3389/fcell.2018.00097
  24. Surgically Treated Community-Acquired Brain Abscess: Bacteriological Analysis Based on Predisposing Infections vol.71, pp.3, 2018, https://doi.org/10.7883/yoken.jjid.2017.425
  25. Primary Drug-Resistance Pattern and Trend in Elderly Tuberculosis Patients in Shandong, China, from 2004 to 2019 vol.13, pp.None, 2012, https://doi.org/10.2147/idr.s277203
  26. Predicting the impact of control strategies on the tuberculosis burden in South and North Korea using a mathematical model vol.6, pp.10, 2021, https://doi.org/10.1136/bmjgh-2021-005953